Game-Changing cervical cancer prevention: Same-Day test and treat in one visit

NCT ID NCT07232355

Recruiting now Prevention Sponsor: Atila Biosystems Inc. Source: ClinicalTrials.gov ↗

First seen Nov 18, 2025 · Last updated May 24, 2026 · Updated 19 times

Summary

This study aims to prevent cervical cancer by testing women for high-risk HPV and offering same-day treatment if needed. About 5,000 women in Honduras will use a self-sampling kit or have a provider-collected sample. The test gives results in under an hour, and AI imaging helps decide who needs treatment, reducing the need for follow-up visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Atila Biosystems, Inc.
RECRUITING

Sunnyvale, California, 94085, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Basic Health International
RECRUITING

San Salvador, El Salvador

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centro de Salud Las Crucitas
RECRUITING

Tegucigalpa, Honduras

Contact Email: •••••@•••••
Ciudad Mujer Kennedy
RECRUITING

Tegucigalpa, Honduras

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HUMAN PAPILLOMA VIRUS